Graeme Bell to Cost-Benefit Analysis
This is a "connection" page, showing publications Graeme Bell has written about Cost-Benefit Analysis.
Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011 Mar; 34(3):622-7.